As set out in the Network North command paper, for the historic Phase 1 scope DfT officials have estimated a provisional range of £45 billion to £54 billion.<\/p>
Given these cost assessments were made before the decision was taken to cancel Phase 2, the Department has asked HS2 Ltd to consider the revised scope of the project and provide an action plan on how it will deliver this at the lowest reasonable cost. We will be able to provide more information in due course.<\/p>
Delivery remains on track for the initial high-speed services between Old Oak Common in west London and Birmingham Curzon Street by 2029 to 2033. An updated delivery-into-service range for services to Euston will be provided in due course.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4499", "label" : {"_value" : "Biography information for Lord Davies of Gower"} } , "answeringMemberPrinted" : {"_value" : "Lord Davies of Gower"} , "dateOfAnswer" : {"_value" : "2024-02-14", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-02-14T15:38:51.38Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "27"} , "answeringDeptShortName" : {"_value" : "Transport"} , "answeringDeptSortName" : {"_value" : "Transport"} , "date" : {"_value" : "2024-02-07", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "High Speed 2 Line"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government what estimate they have made of the cost of completing the first phase of HS2; and what is the projected completion date.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/134", "label" : {"_value" : "Biography information for Lord Framlingham"} } , "tablingMemberPrinted" : [{"_value" : "Lord Framlingham"} ], "uin" : "HL2283"} , {"_about" : "http://data.parliament.uk/resources/1505809", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1505809/answer", "answerText" : {"_value" : "
The Spending Review in 2021 provided £2.3 billion in capital funding for diagnostic services over the next three years. The majority of this funding will be allocated increase the number of community diagnostic centres (CDCs) to 160 by March 2025 and to expand planned elective diagnostic services. In 2022/23, £900 million has been allocated to the CDC programme and to increase capacity for imaging, endoscopy, lung and mammography screening and improving digital diagnostics. The capital allocation has not been diverted to other services. Revenue funding may be lower than originally envisaged in order to meet the cost of the 2022/23 National Health Service pay settlement.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4582", "label" : {"_value" : "Biography information for Baroness Bloomfield of Hinton Waldrist"} } , "answeringMemberPrinted" : {"_value" : "Baroness Bloomfield of Hinton Waldrist"} , "dateOfAnswer" : {"_value" : "2022-09-26", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2022-09-26T12:02:05.9Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2022-09-07", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Community Diagnostic Centres: Finance"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government how much funding was allocated at the start of this financial year for NHS diagnostic centres; and how much of this funding has since been diverted to other NHS services.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4333", "label" : {"_value" : "Biography information for Lord Scriven"} } , "tablingMemberPrinted" : [{"_value" : "Lord Scriven"} ], "uin" : "HL2283"} , {"_about" : "http://data.parliament.uk/resources/1349350", "AnsweringBody" : [{"_value" : "Department for Education"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1349350/answer", "answerText" : {"_value" : "
Draft statutory guidance makes clear that in carrying their reviews, the governing bodies of colleges will need to ensure that they comply with their existing statutory obligations, including those related to equality law, under the Equality Act 2010.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4218", "label" : {"_value" : "Biography information for Baroness Berridge"} } , "answeringMemberPrinted" : {"_value" : "Baroness Berridge"} , "dateOfAnswer" : {"_value" : "2021-07-29", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "HL2282"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-07-29T14:51:07.18Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "60"} , "answeringDeptShortName" : {"_value" : "Education"} , "answeringDeptSortName" : {"_value" : "Education"} , "date" : {"_value" : "2021-07-21", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Further Education: Ethnic Groups"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what steps they are taking to ensure that the (1) guidance, and (2) duty being placed on colleges, to review local skills provision includes guidance on advancing race equality in further education.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4722", "label" : {"_value" : "Biography information for Lord Woolley of Woodford"} } , "tablingMemberPrinted" : [{"_value" : "Lord Woolley of Woodford"} ], "uin" : "HL2283"} , {"_about" : "http://data.parliament.uk/resources/1183191", "AnsweringBody" : [{"_value" : "Department for Digital, Culture, Media and Sport"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1183191/answer", "answerText" : {"_value" : "
The Government announced on 9 March that it had agreed a deal with the mobile network operators to deliver the Shared Rural Network programme. This will see Government and industry jointly invest to increase 4G mobile coverage throughout the UK to 95% geographic coverage by end-2025. Coverage is based on Ofcom\u2019s definition of good quality 4G coverage, which is the minimum signal strength required to deliver a 90-second telephone call and a download speed of at least 2Mbit/s, 95% of the time.<\/p>
The Shared Rural Network is underpinned by legally binding coverage commitments from each operator to have reached at least 90%, which will be assessed in 2026. Ofcom will regularly report on coverage improvements towards this goal through its Connected Nations report.<\/p>
Exact site deployment plans will be managed by the operators themselves in order for them to best deliver the agreed coverage outcomes. However, we expect that consumers will feel the benefit of the programme long before its conclusion and the operators will consult with communities as roll out plans become clearer.<\/p>
While the biggest improvements in coverage arising from the Shared Rural Network will be in Scotland and Wales, there will be improvements across all four nations. 4G geographic coverage in England is currently 97% from at least one operator and 81% from all four operators. As a result of the programme, this will increase to 98% coverage from at least one operator, and 90% from all four by end-2025.<\/p>
The Shared Rural Network will help close the digital divide between urban and rural areas by improving mobile coverage in largely rural areas across the whole of the UK. The programme is not directly aimed at improving coverage in dense inner-city areas such as the West End of London which, typically, have good 4G coverage from all four operators, and it will remain a commercial decision for operators to decide whether to improve coverage in such areas.<\/p>
We are aware of the European Commission\u2019s Digital Economy and Society Index report 2019, which compares 4G coverage of homes across Member States. The report, available via the following link, https://ec.europa.eu/digital-single-market/en/desi<\/a> suggests that in 2018, based on an average of operator coverage, there was 98% 4G coverage of UK homes. This compared to 95% for France, and an EU average of 94%. The Shared Rural Network will help to improve our European standing by providing additional coverage to 280,000 premises.<\/p> While the vast majority of commercial rollout of 5G services will be delivered by industry and according to their own timeframes, government is committed to being a world leader in 5G technology and providing a 5G signal to a majority of the population by 2027. The Government is investing in a nationally coordinated programme of 5G testbed facilities and application trials to help achieve this, and has allocated £200 million from the National Productivity Investment Fund to the 5G Programme, which launched in 2017 and will run until March 2022.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4703", "label" : {"_value" : "Biography information for Baroness Barran"}
}
, "answeringMemberPrinted" : {"_value" : "Baroness Barran"}
, "dateOfAnswer" : {"_value" : "2020-03-16", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "HL2278"}
, {"_value" : "HL2279"}
, {"_value" : "HL2280"}
, {"_value" : "HL2281"}
, {"_value" : "HL2282"}
, {"_value" : "HL2350"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2020-03-16T16:31:57.903Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "10"}
, "answeringDeptShortName" : {"_value" : "Digital, Culture, Media and Sport"}
, "answeringDeptSortName" : {"_value" : "Digital, Culture, Media and Sport"}
, "date" : {"_value" : "2020-03-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "4G"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask Her Majesty's Government what assessment they have made of the reliability of 4G in the UK compared to EU countries.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/3830", "label" : {"_value" : "Biography information for Lord Mawson"}
}
, "tablingMemberPrinted" : [{"_value" : "Lord Mawson"}
], "uin" : "HL2283"}
, {"_about" : "http://data.parliament.uk/resources/773568", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/773568/answer", "answerText" : {"_value" : " Anyone suffering ill health deserves access to appropriate clinical investigation and care, and to be treated with dignity and respect. This is an important responsibility of doctors and other healthcare providers.<\/p> The Medicines and Healthcare products Regulatory Agency takes every report of a suspected adverse reaction seriously and has closely evaluated the safety of the human papillomavirus vaccine since the vaccination programme was introduced in the United Kingdom in 2008. All reports, including any submitted by patients and their families, are kept under continual review to identify potential new risks.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4545", "label" : {"_value" : "Biography information for Lord O'Shaughnessy"}
}
, "answeringMemberPrinted" : {"_value" : "Lord O'Shaughnessy"}
, "dateOfAnswer" : {"_value" : "2017-11-01", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-11-01T12:47:48.597Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-10-19", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Human Papillomavirus: Vaccination"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask Her Majesty's Government what steps they are taking to ensure that the families of children believed to have suffered serious adverse reactions to human papilloma virus vaccinations are treated with the same levels of dignity and respect accorded to families whose children have other medical conditions.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1861", "label" : {"_value" : "Biography information for The Countess of Mar"}
}
, "tablingMemberPrinted" : [{"_value" : "The Countess of Mar"}
], "uin" : "HL2283"}
, {"_about" : "http://data.parliament.uk/resources/600530", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/600530/answer", "answerText" : {"_value" : " The Environment Agency (EA) has recently restructured its senior management team following a voluntary exit scheme and has filled all vacancies within the Energy Saving Opportunity Scheme (ESOS) senior team.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4284", "label" : {"_value" : "Biography information for Baroness Neville-Rolfe"}
}
, "answeringMemberPrinted" : {"_value" : "Baroness Neville-Rolfe"}
, "dateOfAnswer" : {"_value" : "2016-10-19", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2016-10-19T13:26:25.943Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "201"}
, "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"}
, "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"}
, "date" : {"_value" : "2016-10-12", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Energy: Conservation"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask Her Majesty\u2019s Government what steps they are taking to fill senior management vacancies on the Energy Savings Opportunity Scheme.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/621", "label" : {"_value" : "Biography information for Lord Moonie"}
}
, "tablingMemberPrinted" : [{"_value" : "Lord Moonie"}
], "uin" : "HL2283"}
, {"_about" : "http://data.parliament.uk/resources/419210", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/419210/answer", "answerText" : {"_value" : " Ensuring that the National Health Service is able to support the availability and use of effective medicines for cancers, including rare blood cancer, is a key priority.<\/p> <\/p> <\/p> <\/p> Cancer 52, an organisation which specifically represents patients with rarer cancers, was represented on the independent Cancer Taskforce. The Taskforce published its report, Achieving World-Class Cancer Outcomes: A Strategy for England 2015-2020<\/em>, in July, and made many recommendations relevant to rarer and blood cancers, focussing in particular on improving access to diagnostic testing, including fast, direct general practitioner access to key blood tests, and increasing patient access to the most advanced treatments. NHS England, Public Health England and other healthcare organisations are now considering the detail of the individual recommendations.<\/p> <\/p> <\/p> <\/p> Earlier in 2015, NHS England consulted on the principles and process by which it makes investment decisions in specialised services, which address the issue of rarity. The outcome of future investment decisions taken by NHS England will be published in accordance with the new process. NHS England\u2019s response to the consultation is attached, and can be found at:<\/p> <\/p> <\/p> <\/p>